Humalog Mix25 improves 24-hour plasma glucose profiles compared with the human insulin mixture 30/70 in patients with type 2 diabetes mellitus

  • M Herz
  • V Arora
  • B N Campaigne
  • H E Scholtz
  • M A Potgieter
  • W Mollentze


Objective. To compare the effects of Humalog Mix25 (Humalog Mix75/25 in the USA) (Mix25) and human insulin 30/70 (30/70) on the 24-hour inpatient plasma glucose (PG) profile in patients with type 2 diabetes mellitus (T2DM). Design. A randomised, open-label, 8-week crossover study. Study insulins were injected twice daily, 5 minutes before breakfast and dinner. Setting. Four-week outpatient (dose-adjustment) treatment phase, and 3-day inpatient (test) phase. Patients. Twenty-five insulin-treated patients with T2DM (ages 40 - 66 years), mean (± standard error of the mean) (SEM) HbA1c 7.7% ± 0.23%, and body mass index (BMI) 29.3 ± 0.83 kg/m2. Outcome measures. 24-hour PG profiles, PG excursions after meals, PG area under the curve (AUC), and 30-day hypoglycaemia rate. Results. The 2-hour PG excursions following breakfast (5.5 ± 0.34 v. 7.2 ± 0.34 mmol/l, p = 0.002) and dinner (2.4 ± 0.27 v. 3.4 ± 0.27 mmol/l, p = 0.018) were smaller with Mix25 than with 30/70. PG AUC between breakfast and lunch was smaller with Mix25 than with 30/70 (77.6 ± 3.8 v. 89.5 ± 4.3 mmol/h/ml, p = 0.001). PG AUC between lunch and dinner, dinner and bedtime, and bedtime and breakfast did not differ between treatments. Pre-meal and nocturnal PG were comparable. The postprandial insulin requirement for lunch meals was supplied equally by the two insulin treatments. The thirty-day hypoglycaemia rate was low (Mix25 0.049 ± 0.018 v. 30/70 0.100 ± 0.018 episodes/patient/30 days, p = 0.586) for both treatments. Conclusion. In patients with T2DM, Mix25 improved the 24-hour PG profile with lower postprandial PG excursions than with human insulin 30/70.

(South African Medical Journal: 2003 93(3): 219-223)

Journal Identifiers

eISSN: 0256-95749
print ISSN: 2078-5135